The use of clozapine in the treatment of aggressive schizophrenia

Canadian Journal of Psychiatry

Volumn 43, Issue 5, 1998, Pages 466-472

  Ian Hector, R ^a,b  

^a Mental Health Centre Penetanguishene   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aggression; Agranulocytosis; Assault; Atypical antipsychotic; Clozapine; Polydipsia; Seclusion; Staff injury; Tardive dyskinesia; Violence

Indexed keywords

CHLORPROMAZINE; CIMETIDINE; CLOZAPINE; DIGITOXIN; FLUOXETINE; FLUPHENAZINE DECANOATE; FLUVOXAMINE; HALOPERIDOL; LOXAPINE; NEUROLEPTIC AGENT; PERPHENAZINE; PIMOZIDE; SEROTONIN UPTAKE INHIBITOR; TRIFLUOPERAZINE; WARFARIN; ZUCLOPENTHIXOL;

AGGRESSION; AGRANULOCYTOSIS; DRUG INDUCED DISEASE; HUMAN; MENTAL DISEASE; POLYDIPSIA; PSYCHOPHARMACOTHERAPY; REVIEW; SCHIZOPHRENIA; TARDIVE DYSKINESIA; TREATMENT OUTCOME; VIOLENCE;

EID: 3643071807     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379804300503     Document Type: Review

References (54)

1. Kapur S. Receptor imaging studies in the treatment of schizophrenia. Psychiatry Rounds 1998;2:1-5.
2. Clozaril Support and Assistance Network (CSAN). Database. Novartis Pharmaceuticals Canada Inc; 1996.
3. Lieberman JA, Saltz BL, Johns CA, Pollack S, Borenstein M, Kane J. The effects of clozapine on tardive dyskinesia. Br J Psychiatry 1991;158:503-10.
4. Krupp P, Barnes P. Clozapine-associated agranulocytosis: risk and etiology. Br J Psychiatry 1992;17:38-40.
5. Popli AP, Konicki PE, Jurjus GJ, Fuller MA, Jaskiw GE. Clozapine and associated diabetes mellitus. J Clin Psychiatry 1997;58:108-11.
6. Drew L, Herdson P. Clozapine and constipation: a serious issue. Aust N Z J Psychiatry 1997;31:149-50.
7. Meltzer HY, Bastani B, Kwon KY, Ramirez LF, Burnett S, Sharpe J. A prospective study of clozapine in treatment-resistant schizophrenic patients. Psychopharmacology 1989;99(Suppl):68S-72S.
8. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-96.
9. Lindstrom LH. The effect of long term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatr Scand 1988;77:524-9.
10. Ratey JN, Leveroni C, Kilmer D, and others. The effects of clozapine of severely aggressive psychiatric inpatients in a state hospital. J Clin Psychiatry 1993;54:219-23.
11. Wilson WH. Clinical review of clozapine treatment in a state hospital. Hospital and Community Psychiatry 1992;43:700-33.
12. Rabinovitz J, Avnon M, Rosenberg V. Effect of clozapine on physical and verbal aggression. Schizophr Res 1996;22:249-55.
13. Volavka J, Vito J, Czobor P. Clozapine effects on hostility and aggression in schizophrenia. J Clin Psychopharmacol 1993;13:287-9.
14. Buckley P, Bartell J, Donenwirth K, Lee S, Torigoe F, Schulz SC. Violence and schizophrenia: clozapine as a specific antiaggressive agent. Bull Am Acad Psychiatry Law 1995;23:607-11.
15. Buckley PF, Kausch O, Gardiner G. Clozapine treatment of schizophrenia: implication for forensic psychiatry. Cited in: Buckley P, Bartell J, Donenwirth K, Lee S, Torigoe F, Schulz SC. Violence and schizophrenia: clozapine as a specific antiaggressive agent. Bull Am Acad Psychiatry Law 1995;23:607-11.
16. Eichelman B. Aggressive behavior: from the laboratory to clinic. Arch Gen Psychiatry 1992;49:488-92.
17. Lang A, Harro J, Soosaar A, Volke V, Oreland L, Bourin M, and others. Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behavior in rats. Naunyn-Schmiedebergs Archives of Pharmacology 1995;351:363-70.
18. Brown GL, Good win FK, Ballenger JC. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1979;1:131-9.
19. Linnoila VMI, Virkkunen M. Aggression, suicide, and serotonin, J Clin Psychiatry 1992;53(10 Suppl):46S-51S.
20. Roth BL, Craigo SC Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, and others. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and S-hydroxytryptamine-V receptors. J Pharmacol ExpTher 1994;268:1403-10.
21. Garmendia L, Sanchez JR, Azpiroz A, Brain PF, Simon VM Clozapine: strong antiaggressive effects with minimal motor impairment. Physiol Behav 1991;51:51-4.
22. Herrera JN, Sramek JJ, Costa JF, Roy S, Heh CW, Nguyen BN. High potency neuroleptics and violence in schizophrenics. J Nerv Ment Dis 1988;176:558-61.
23. Kinon BJ, Kane JM, Johns C, Perovich R, Ismi M, Koreen A, and others. Treatment of neuroleplic-resistant schizophrenic relapse. Psychopharmacol Bull 1993;29:309-14.
24. Torrey EF. Evaluation of the relationship between violence and serious mental illness. Hospital and Community Psychiatry 1994;45:482-8.
25. Tardiff H. The current state of psychiatry in the treatment of violent patients. Arch Gen Psychiatry 1992;49:493-9.
26. Monohan J, Steadman N, Crime and mental disorder: an epidemiological approach. In: Morris N, Tonry M, editors. Crime and justice: an annual review of research, Volume 4. Chicago: Chicago University Press; 1983.
27. Canadian Mental Health Association. Response to the Chief Coroner for Ontario regarding the Coroner's Jury Recommendations from the Inquest into the death of Brian Smith. Feb 1998.
28. Huston AC, Donnerstein E, Fairchild H, Feshbach N, Katz P. Big world, small screen. Lincoln (NB): University of Nebraska Press; 1992.
29. Swanson JW, Holzer CE, Ganju V, Jono RT. Violence and psychiatric disorder in the community; evidence from the Epidemiologic Catchment Area Surveys. Hospital and Community Psychiatry 1990;41:761-70.
30. Link B, Andrews H, Cullen FT. The violent and illegal behavior of mental patients reconsidered American Sociological Review 1992;57:275-92.
31. Morrison EF. A hierarchy of aggressive and violent behaviors among psychiatric inpatients. Hospital and Community Psychiatry 1992;43:505-6.
32. Taylor PJ. Schizophrenia and crime: distinctive patterns in association. In: Hodgins S, editor. Crime and mental disorder. Newbury Park (CA): Sage Publications; 1993.
33. Wessely SC, Castle D, Douglas AJ, Taylor PJ. The criminal careers of incident cases of schizophrenia. Psychol Med 1994;24:483-502.
34. Johnstone EC, Crow TJ, Johnson AL, MacMillan JF. The Northwick Park study of first episodes of schizophrenia. Br J Psychiatry 1986;148:115-20.
35. Mulvey ER Assessing the evidence of a link between mental illness and violence-Hospital and Community Psychiatry 1994;45:663-8.
36. Cote G, Hodgins S. The prevalence of major mental disorders among homicide offenders. Int J Law Psychiatry 1992;15:89-99.
37. Cheung P, Schweitzer I, Crowley K, Tuckwell V. Violence in schizophrenia: role of hallucinations and delusions. Schizophr Res 1997;26:181-90.
38. Kasper MR, RogersT, Adams PA. Dangerousness and command hallucinations. Bull Am Acad Psychiatry Law 1996;24:219-24.
39. Rogers R, Nussbaum D, Gillis JR. Command hallucinations and criminality: a clinical quandary. Bull Am Acad Psychiatry Law 1988;16:251-8.
40. Taylor PJ. Schizophrenia and the risk of violence. In: Hirsch S, Weinberger D, editors. Schizophrenia. Oxford: Blackwell Science, p 163-83.
41. Bleuler E. Textbook of Psychiatry. Brill AA, translator. New York: MacMillan; 1924.
42. Silva JA, Leong GB, Weinstock R, Wine DB. Delusional misidentification and dangerousness: aneurobiological hypothesis. J Forensic Sci 1993;38:904-13
43. Movat RR. Morbid jealousy and murder. London: International Library of Criminology Delinquency and Deviant Social Behavior; 1966.
44. Johnson B, Martin L, Guha M, Montgomery P. The experience of thought-disordered individuals preceding an aggressive incident. Journal of Psychiatric and Mental Health Nursing 1997;4:213-20.
45. Kroll J, MacKenzie T. When psychiatrists are liable: risk management and violent patients. Hospital and Community Psychiatry 1986;34:29-37.
46. Hiday VA. Understanding the connection between mental illness and violence. American Sociological Review 1992;57:272-5.
47. Cuffel BJ, Shumway M, Chouljiam TL, MacDonald T. A longitudinal study of substance use and community violence in schizophrenia. J Nerv Ment Dis 1994;182:704-8.
48. Meltzer HY. Suicidality and clozapine. J Clin Psychiatry Monograph 1996;14:13-14.
49. Michals M, Crismon M, Roberts S, Childs A.Clozapine response and adverse effects in nine brain-injured patients. J Clin Psychopharmacol 1993;13:198-203.
50. Hammock RG, Schroeder SR, Levine WR, The effect of clozapine on self-injurious behavior. J Autism Dev Disord 1995;25:611-26.
51. Cohen SA, Underwood MT. The use of clozapine in a mentally retarded and aggressive population. J Clin Psychiatry 1944;55:440-4.
52. Su T, Tuskan J, Tsao L, and others. Aggression during drug-free and antipsychotic treatment in patients with chronic schizophrenia, using the overt aggression scale. In: The American College of Neuropyschopharmacology Meeting; 1994; San Juan.
53. Mallya AR, Roos PD, Roebuck-Cokan K. Restraint, seclusion and clozapine. J Clin Psychiatry 1992;23:395-7.
54. Hunter M, Carmel H. The cost of staff injuries from inpatient violence. Hospital and Community Psychiatry 1996;43:586-8.